Mordor Intelligence

Activities: Media

Trending Articles

  1. Touchlight becomes the first synthetic DNA API manufacturer to receive GMP certification The CDMO's Hampton, UK facility has received GMP certification to produce investigational APIs and critical starting materials for DNA vaccines and non-viral gene therapies
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Managing airflow, contamination risks and technician well-being with biological safety cabinets Microbiology labs and other facilities researching biohazardous materials and pathogens such as bacteria, viruses and fungi must avoid contamination. It is critical to ensure...
  3. Daiichi Sankyo and BioMed X Institute join forces to develop multi-specific biologics for cancer therapy Through this collaboration, they aim to discover and develop novel target combinations for bi- and multi-specific biologics for the treatment of solid tumours
  4. Teva Pharmaceuticals, Klinge Pharma and Formycon join forces to commercialise Eylea biosimilar FYB203, which will be marketed under the name AHZANTIVE®3 if approved by the EMA, will be commercialised by Teva Pharmaceuticals in the majority of Europe and Israel
  5. Vetter launches new iteration of the V-OVS syringe closure system The new version is optimised to protect the integrity of the injectable product with easier handling characteristics and an intuitive opening mechanism

Upcoming event

Pharmapack

22 – 23 January 2025 | Exhibition | Paris, France See all

Related Content

Media

Global ampoules and blister packaging market expected to be worth US$14.81bn by 2020, finds report

Blister packaging expected to be highest growing material for pharma products in North America
Subscribe now